Keywords: strong, long-term, cd, data, humira, new, show
Strong long-term CD data on Humira
Article | 02 June 2008
New data show that adult moderate-to-severe Crohn's disease patients treated with Abbott Laboratories' Humira (adalimumab) achieved long-term clinical remission and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
